Quality appraisal of clinical practice guidelines on pancreatic cancer

Medicine (United States)

Volumn 94, Issue 12, 2015, Pages e635-

  He, Zhiyun ^a,b   Tian, Hongliang ^c   Song, Ailin ^b   Jin, Lan ^a   Zhou, Xiaona ^a   Liu, Xiaoye ^a   Guo, Wei ^a   Zhang, Zhongtao ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHINESE BIOMEDICAL DATABASE; CNKI DATABASE; DATA EXTRACTION; EMBASE; HUMAN; MEDICAL EXPERT; MEDLINE; METHODOLOGY; PANCREAS CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; QUALITY CONTROL; SYSTEMATIC REVIEW; WANFANG DATABASE; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; PANCREAS TUMOR; PROCEDURES; STATISTICS AND NUMERICAL DATA;

EVIDENCE-BASED MEDICINE; HUMANS; PANCREATIC NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; QUALITY ASSURANCE, HEALTH CARE;

EID: 84926683655     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000635     Document Type: Article

References (41)

1. Institute of Medicine. Clinical Practice Guidelines We Can Trust. Washington, DC: The National Academies Press; 2011
2. Brouwers MC, Kho ME, Browman GP, et al AGREE next steps consortium AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010; 18:E839-E842
3. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics. CA Cancer J Clin. 2001; 51:15-36
4. Bramhall SR, Allum WH, Jones AG, et al. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg. 1995; 82:111-115
5. Long J, Luo GP, Xiao ZW, et al. Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China. Cancer Lett. 2014; 346:273-277
6. Zadvinskis IM, Grudell BA. Clinical practice guideline appraisal using the AGREE instrument. Clin Nurse Spec. 2010; 4:09-14
7. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979; 2:420-428
8. Ulrich CD. Consensus Committees of the European Registry of Hereditary Pancreatic Diseases; Midwest Multi-Center Pancreatic Study Group; International Association of Pancreatology. Pancreatic cancer in hereditary pancreatitis: consensus guidelines for prevention, screening and treatment. Pancreatology. 2001; 1:416-422
9. R. L Akehurst, David Barnett, Colin Berry, et al. Guidance on the Use of Gemcitabine for the Treatment of Pancreatic Cancer. NICE Technology Appraisal Guidance - No.25. National Institute for Health and Care Excellence (NICE) May, 2001
10. Pancreatric Section, British Society of Gastroenterology; Pancreatic Society of Great Britain and Ireland; Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland; Royal College of Pathologists; Special Interest Group for Gastro-Intestinal Radiology. Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut. 2005; 54 (suppl 5): v1-v16
11. Division of Pancreatic Surgery Branch of Surgery, Chinese Medical Association. Guideline for diagnosis and treatment of pancreatic cancer. Chin J Hepatobiliary Surg. 2008; 3:198-200
12. Hidalgo M, Abad A, Aranda E, et al. Consensus on the treatment of pancreatic cancer in Spain. Clin Transl Oncol. 2009; 5:290-301
13. Cascinu S, Jelic S. ESMO Guidelines Working Group. Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol. 2009; 20 (suppl 4):37-40
14. Callery MP, Chang KJ, Fishman EK, et al. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement Ann Surg Oncol. 2009; 16:1727-1733
15. Evans DB, Farnell MB, Lillemoe KD, et al. Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement Ann Surg Oncol. 2009; 16:1736-1744
16. Kanjeekal S, Biagi J, Walker-Dilks C. PET Imaging in pancreatic cancer. Toronto (ON): Cancer Care Ontario [In review 2012 Jun.]. Program in Evidence-based Care PET Recommendation Report No.: 5
17. Cascinu S1, Falconi M, Valentini V, et al., ESMO Guidelines Working Group. Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol. 2010; 21 (suppl 5):v55-v58
18. Gómez-Martín C, Hidalgo M, Tabernero J, et al. SEOM clinical guidelines for the treatment of pancreatic cancer. Clin Transl Oncol. 2011; 13:528-535
19. Hammad N, Cosby R, Biagi J. The Use of FOLFIRINOX as First-Line Treatment for Metastatic Pancreatic Adenocarcinoma. Toronto (ON): Cancer Care Ontario. Program in Evidence-based Care Evidence-Based Series. 2011; No.: 2-18
20. Germond C, Maroun J, Moore M, and Members of the Gastrointestinal Cancer Disease Site Group. Use of Gemcitabine in the Treatment of Advanced Pancreatic Adenocarcinoma. Toronto (ON): Cancer Care Ontario [Archived July 12, 2010]. Program in Evidence-based Care Evidence-Based Series No.: 2-10 Archived 2011
21. Seufferlein T, Bachet JB, Van Cutsem E, et al., ESMO Guidelines Working Group. Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol. 2012; 23 (suppl 7):vii33-vii40
22. Tempero MA, Arnoletti JP, Behrman SW, et al., National Comprehensive Cancer Networks. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2012; 10:703-713
23. Interventional Organization, Radiology Branch. Guide to intraarterial infusion chemotherapy for pancreatic cancers (draft text). J Interv Radiol. 2012; 21:353-355
24. Division of Pancreatic Cancer Branch of Oncology Chinese Medical Association. Expert consensus on multidisciplinary treatment for pancreatic cancer. Chin J Oncol. 2013; 35:398-400
25. Members of the Gastrointestinal Cancer Disease Site Group. The Treatment of Locally Advanced Pancreatic Cancer. In: Earle C, Tey R, reviewers. Toronto (ON): Cancer Care Ontario [Endorsed July 29, 2010]. Program in Evidence-based Care Evidence-Based Series 2013; No.: 2-7 Version 2
26. National Institute for Health and Care Excellence (NICE). Irreversible Electroporation for Treating Pancreatic Cancer.National Institute for Health and Care Excellence (NICE); 2013
27. National Comprehensive Cancer Network (NCCN). NCCN Guidelines Version 1.2014 Pancreatic Adenocarcinoma.National Comprehensive Cancer Network (NCCN); 2014
28. Expert Committee of Pancreatic Cancer Chinese Clinical Oncology Association. Diagnosis and treatment for pancreatic cancer: expert consensus statement in China. Chin Clin Oncol. 2014; 14:358-370
29. Zhang ZW, Liu XW, Xu BC, et al Analysis of quality of clinical practice guidelines for otorhinolaryngology in China. PLoS One. 2013; 8:e53566
30. Grol R, Cluzeau FA, Burgers JS. Clinical practice guidelines: towards better quality guidelines and increased international collaboration. Br J Cancer. 2003; 89 (suppl 1):S4-S8
31. Alonso-Coello P, Irfan A, Solà I, et al. The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies. Qual Saf Health Care. 2010; 19:e58
32. Shekelle P, Eccles MP, Grimshaw JM, et al. When should clinical guidelines be updated?. BMJ. 2001; 323:155-157
33. Huang TW, Lai JH, Wu MY, et al. Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer. BMC Med. 2013; 11:191
34. Shekelle PG, Ortiz E, Rhodes S, et al. Validity of the agency for healthcare research and quality clinical practice guidelines: how quickly do guidelines become outdated?. JAMA. 2001; 286:1461-1467
35. Hirsh J, Guyatt G. Clinical experts or methodologists to write clinical guidelines?. Lancet. 2009; 9686:273-275
36. Schünemann HJ, Hill SR, Kakad M, et al. Transparent development of the WHO rapid advice guidelines. PLoS Med. 2007; 4:e119
37. Schünemann HJ, Osborne M, Moss J, et al., ATS Ethics and Conflict of Interest Committee and the Documents Development and Implementation Committee An official American Thoracic Society Policy statement: managing conflict of interest in professional societies Am J Respir Crit Care Med. 2009; 180:564-580
38. GRADE working group. http://www.gradeworkinggroup.org/.news.htm Accessed December 23, 2011
39. Brozek JL, Akl EA, Alonso-Coello P, et al., GRADE Working Group. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3 An overview of the GRADE approach and grading quality of evidence about interventions Allergy. 2009; 64:669-677
40. Brozek JL, Akl EA, Alonso-Coello P, et al., GRADE Working Group. Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies Allergy. 2009; 64:1109-1116
41. Fervers B, Burgers JS, Haugh MC, et al Adaptation of clinical guidelines: literature review and proposition for a framework and procedure. Int J Qual Health Care. 2006; 18:167-176